Silent atrial fibrillation: clinical management and perspectives.


Journal

Future cardiology
ISSN: 1744-8298
Titre abrégé: Future Cardiol
Pays: England
ID NLM: 101239345

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 4 3 2020
medline: 12 8 2021
entrez: 4 3 2020
Statut: ppublish

Résumé

Silent atrial fibrillation (AF) is an asymptomatic atrial arrhythmia that can be diagnosed by chance during a systematic electrocardiogram, an external Holter, or from implanted cardiac devices. There is a significant body of the literature around silent AF, yet it remains largely underdiagnosed in everyday clinical practice. Meanwhile, new diagnostic tools have significantly improved the detection of silent AF, creating a potential for mass screening via new technologies and the promise of a major step forward in e-health progress. However, it is not yet known whether silent AF is associated with the same thromboembolic risk as symptomatic AF, and whether these asymptomatic and often short-lasting episodes therefore require anticoagulation therapy and rhythm management.

Identifiants

pubmed: 32125174
doi: 10.2217/fca-2019-0066
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-142

Auteurs

Charles Guenancia (C)

Department of Cardiology, University Hospital, 21000 Dijon, France.
PEC2, EA 7460, 21000 Dijon, France.

Fabien Garnier (F)

Department of Cardiology, University Hospital, 21000 Dijon, France.

Marie Fichot (M)

Department of Cardiology, University Hospital, 21000 Dijon, France.

Audrey Sagnard (A)

Department of Cardiology, University Hospital, 21000 Dijon, France.

Gabriel Laurent (G)

Department of Cardiology, University Hospital, 21000 Dijon, France.

Luc Lorgis (L)

Department of Cardiology, University Hospital, 21000 Dijon, France.
PEC2, EA 7460, 21000 Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH